DGTR tracker

DGTR opens anti-dumping investigation into Penicillin G and its salts from China

The application was filed by Lyfius Pharma Private Limited, which claims that the Indian Penicillin G industry had completely shut down because of dumped imports and that it began producing the like article in FY 2024-25. It alleges that dumped imports are causing material retardation to the establishment of the domestic industry.

SETU CASE ID - AD/OI/057/2026 · Initiation · September 28, 2026

IndusDesk ·

The Directorate General of Trade Remedies has initiated an anti-dumping investigation concerning imports of Penicillin G and its salts from China, by notification dated September 28, 2026 (SETU Case ID AD/OI/057/2026).

The application was filed by Lyfius Pharma Private Limited, which claims that the Indian Penicillin G industry had completely shut down because of dumped imports and that it began producing the like article in FY 2024-25. It alleges that dumped imports are causing material retardation to the establishment of the domestic industry. The applicant named China and Hong Kong, but no imports from Hong Kong were found in the period of investigation, so China is the only subject country.

The product covers Penicillin-G (benzylpenicillin) and its salts in all forms, grades, strengths and concentrations, solid and liquid, under sub-heading 2941 10 10; the classification is indicative only. The period of investigation is April 1, 2025 to March 31, 2026, with an injury period covering 2022-23, 2023-24, 2024-25 and the period of investigation.

For initiation, normal value was built from the domestic industry's cost of production, and the comparison with DGCI&S-based export prices shows, prima facie, a dumping margin above de minimis. The Authority also finds prima facie evidence of material retardation and a causal link. It will determine the existence, degree and effect of dumping and recommend any duty needed; the applicant's request for provisional duty will be considered at the appropriate stage. Interested parties are to respond on the SETU portal within 37 days of the intimation letters.

Measure
Anti-dumping
Stage
Initiation
Case number
SETU CASE ID - AD/OI/057/2026
File number
F. No. 6/56/2026-DGTR
Dated
September 28, 2026
Published in the Gazette
September 28, 2026
Put online
October 6, 2026
Gazette ID
CG-DL-E-06102026-276860
Product
Penicillin G and its salts
What it covers
Penicillin-G (benzylpenicillin, chemical name 6-(2-phenylacetamido) penicillanic acid), a beta-lactam antibiotic, in all forms, grades, strengths and concentrations, with its salt forms, whether or not conforming to pharmacopeial standards, and in solid and liquid form. It is used mainly as a key starting material or API for active pharmaceutical ingredients and as an API in finished dosage formulations. The customs classification is indicative only and not binding on the scope.
Customs codes
2941 10 10
Countries
China
Applicant
Lyfius Pharma Private Limited
Period of investigation
1st April 2025 to 31st March 2026
Injury period
the financial years 2022-23, 2023-24, 2024-25 and the period of investigation
Findings
  • The applicant alleged dumping from China and Hong Kong, but DGCI&S data showed no imports from Hong Kong during the period of investigation, so the subject country is China alone.
  • The applicant began production of the like article in FY 2024-25 and states it has not imported the subject goods during the period of investigation; for initiation the Authority considers the other Indian producer, Virchow Petrochemicals Private Limited, part of the domestic industry, notes that the applicant still constitutes a major proportion in terms of Rule 2(b), and finds that the application satisfies the standing requirements of Rule 5(3).
  • Normal value for China was determined on any other reasonable basis under Para 7 of Annexure-I, from the domestic industry's adjusted cost of production plus selling, general and administrative expenses and profit; export price was taken from DGCI&S CIF data, adjusted to ex-factory level.
  • The comparison at ex-factory level shows, prima facie, a dumping margin that is positive and above the de minimis level.
  • The Authority finds sufficient prima facie evidence of material retardation to the establishment of the domestic industry, shown mainly through volume and price effects, with China accounting for virtually all imports during the period of investigation, and of a causal link.
Recommendation
The Authority initiates an anti-dumping investigation under Section 9A of the Act read with Rule 5 of the AD Rules, 1995 to determine the existence, degree and effect of dumping and to recommend the anti-dumping duty adequate to remove injury. The applicant's request for preliminary findings and provisional duty under Rule 13 is to be considered at the appropriate stage, if and to the extent warranted.
Time limits
  • Comments on the scope of the product under consideration and the PCN methodology: within 15 days from the date of transmission of the intimation letters, running concurrently with the main time limit
  • Interested parties to upload confidential and non-confidential questionnaire responses and submissions on the SETU portal under case ID AD/OI/057/2026: within 37 days from the date of transmission of the intimation letters to the known parties and the diplomatic representative(s) of the subject countries, as per Rule 6(4) of the AD Rules, 1995
  • Comments on issues of confidentiality: within 7 days from the date of circulation of the non-confidential version of the documents
  • Requests for extension of time: at least one day before the original deadline

The notification (PDF, 904 KB)

Gazette of India, CG-DL-E-06102026-276860, published September 28, 2026.

Checked against the official copy on October 20, 2026.